Acarbose (Prandase) is now approved for use in COMBINATION with a sulfonylurea

June 1997

Acarbose (Prandase) is now approved for use in combination with a sulfonylurea. It was originally approved as monotherapy.

This combination makes sense.

Each drug works in a different way to lower blood sugar. Together they have additive effects.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Pharmacists are getting very involved with using lab tests to monitor drug theapy
Renal & Urology Adverse sexual effects from SSRI antidepressants are more common
Renal & Urology New drug for benign prostatic hypertrophy, Flomax (tamsulosin)
Diabetes Acarbose (Prandase) is now approved for use in COMBINATION with a sulfonylurea
First Canadian guidelines for treating acute sinusitis
New treatment for external genital and perianal warts, Aldara (imiquimod) cream
Cardiology Hydrochlorothiazide helps reduce heart enlargement in patients with hypertension
Lots of interest these days in omega-3 fatty acids
Pregnenolone (preg-NEEN-o-lone) is the latest hormone to grab the public's attention
Gastroenterology Nicotine patches or enemas for ulcerative colitis
Obesity & Weight Loss Ursodiol (Ursofalk) to PREVENT gallstones
Obesity & Weight Loss Xenical (ZEN-I-cal, orlistat) for obesity
Obesity & Weight Loss Some pharmacists are getting into weight loss counseling
Smoking Cessation New Nicotrol INHALER
Strict drug formularies to control costs
Which components of Premarin are therapeutic